Beyond the Skin: Addressing the Drivers, Psychosocial Impact and Role of Goal Setting in Vitiligo Care
FREE NON-CME Dermatology Webinar
Tuesday, Sept 23, 2025 | 5:00 - 6:00 PM PDT
Mehdi Rashighi, MD
Erik Domingues, MD FAAD
Joanna L. Rosen, PsyD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This webinar will examine the psychosocial impact of vitiligo and examine how timely, individualized care can improve quality of life and patient outcomes.
Learning Objectives:
Understand the impact of the psychosocial burden of vitiligo on patients
Explore how strategies for timely and sustained clinical intervention could improve quality of life and optimize patient outcomes
Explore the importance of setting personalized treatment goals and expectations, tailored to individual patient needs and recognizing progress through meaningful goal achievement
Join us LIVE!
Brought to you by
ABBV-US-02401-E
Conversations in practice: A case-based approach to effective assessment and goal setting in alopecia areata care
FREE NON-CME Dermatology Webinar
Tuesday, November 11, 2025 | 5:00 - 6:00 PM PST
Dr. Carolyn Goh MD, FAAD
Dr. Meena Singh MD, FAAD
Dr. Jennifer Soung MD, FAAD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Explore alopecia areata (AA) from mechanism to management. Gain expert insights into the immune drivers, clinical presentations, and practical, patient-centered approaches that can enhance outcomes and quality of life.
Learning Objectives:
Recognize how the immune-mediated mechanisms of alopecia areata drive its presentation and progression
Understand the myriad nature of presentation and burden for patients with AA
Explore how comprehensive approaches to care can support optimized patient outcomes
Join us LIVE!
Brought to you by
ABBV-US-02401-E
Conversations in practice: A case-based approach to effective assessment and goal setting in alopecia areata care
FREE NON-CME Dermatology Webinar
Tuesday, November 11, 2025 | 5:00-6:00 PM PST
Carolyn Goh MD, FAAD
Meena Singh MD, FAAD
Jennifer Soung MD, FAAD
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Abbvie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Explore alopecia areata (AA) from mechanism to management. Gain expert insights into the immune drivers, clinical presentations, and practical, patient-centered approaches that can enhance outcomes and quality of life.
Learning Objectives:
Recognize how the immune-mediated mechanisms of alopecia areata drive its presentation and progression
Understand the myriad nature of presentation and burden for patients with AA
Explore how comprehensive approaches to care can support optimized patient outcomes
Discuss the various forms of stem cells that are found within the skin
Summarize the integrative approach to hair health and the role of growth factor based therapies
Evaluate the role of stem cell derived topical therapies for post-procedure care
Tailor post-procedure protocols to individual needs
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
AbbVie Medical Affairs + Health Impact
ABBV-US-02514-E
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Unraveling the Mystery: The Role of Type 2 Inflammation Across AD, PN, CSU, and BP
FREE NON-CME Dermatology Webinar
Tuesday, December 9, 2025 | 5:00 PM - 6:00 PM PST
Raj Chovatiya, MD PhD MSCI
Jason Hawkes, MD MS
Erin Barrett, MD
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Sanofi and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Join experts Raj Chovatiya, MD, PhD, MSCI; Jason Hawkes, MD, MS; and Erin Barrett, MD, at the educational ADVENT LearnSkin 2025 Cross-Dermatology Webinar, where they will explore the clinical similarities and differences among AD, PN, CSU, and BP. The discussion will highlight the significance of type 2 inflammation as a common thread in the signs and symptoms of these conditions, as well as the shared and unique inflammatory pathways underlying their pathophysiology.
Learning Objectives:
Understand the clinical similarities and differences in AD, PN, CSU, and BP
Describe the significance of type 2 inflammation in underlying the clinical signs and symptoms of AD, PN, CSU, and BP
Highlight shared and unique type 2 inflammatory pathways in the pathophysiology of these chronic inflammatory dermatologic conditions
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
Obesity in Dermatology: Managing Metabolic Inflammation and Lifestyle Integration
FREE NON-CME Dermatology Webinar
Tuesday, January 6, 2026 | 5:00 PM - 6:00 PM PST
Raja Sivamani, MD MS AP
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Lilly and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This session explores the connection between adipose tissue, systemic inflammation, and their downstream effects on dermatologic disease, highlighting key metabolic pathways that influence skin outcomes. Faculty will also introduce incretin-based therapies and discuss their emerging relevance in inflammatory skin conditions. Building on this foundation, the session provides practical, time-efficient strategies for initiating lifestyle conversations in busy dermatology settings, with examples of achievable diet and exercise recommendations. Participants will leave with actionable approaches for integrating lifestyle interventions into comprehensive dermatologic care plans.
Learning Objectives:
Segment 1: Inflammation, Weight, and Dermatologic Outcomes (30 mins)
-Explain how adipose tissue contributes to chronic systemic and cutaneous inflammation.
-Explore the clinical relevance of metabolic pathways in dermatologic disease.
-Introduce incretin-based therapies and their emerging role in inflammatory skin conditions.
Segment 2: Lifestyle Strategies for Dermatology Practice (30 mins)
-Describe efficient methods for initiating lifestyle discussions during short dermatology visits.
-Provide practical examples of achievable diet and exercise recommendations.
-Discuss how to integrate lifestyle interventions into dermatologic care plans.
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Sponsored by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Psoriasis: Evolving Therapies and
Whole-Patient Management
FREE NON-CME Dermatology Webinar
Tuesday, February 3, 2026 | 5:00 PM - 6:00 PM PST
G. Michael Lewitt, MD
Tina Bhutani, MD MAS
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Lilly and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This session provides an up-to-date review of the evolving psoriasis treatment landscape, highlighting how to thoughtfully select and personalize biologic therapies based on individual patient profiles. Faculty will explore emerging combination and sequencing strategies for moderate-to-severe disease, offering practical insights for real-world decision-making. The session also examines the systemic nature of psoriasis, including its associations with cardiometabolic disease, and outlines best practices for comorbidity screening and whole-patient care. Participants will gain guidance on integrating quality-of-life considerations and long-term management planning into comprehensive treatment approaches.
Learning Objectives:
Segment 1: Evolving Therapies and Personalization (30 mins) - Michael G. Lewitt, MD
-Explore the current and emerging therapeutic landscape.
-Discuss biologic selection and treatment tailoring based on patient profiles.
-Introduce combination and sequencing strategies for moderate-to-severe PsO.
Segment 2: Systemic Implications and Whole-Patient Care (30 mins) - Tina Bhutani, MD MAS
-Address the links between psoriasis, cardiometabolic disease, and systemic inflammation.
-Review comorbidity screening and integrated care approaches.
-Highlight quality-of-life and long-term management considerations.
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Supported by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Explore EBGLYSS® (lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
FREE NON-CME Dermatology Webinar
Tuesday, December 2, 2025 | 5:00 PM - 6:00 PM PST
Saakshi Khattri, MBBS, MD, FAAD, FACR
DAYS
HRS
MIN
SEC
This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com.
Please see Instructions for Use included with the device.EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases.
Learning Objectives:
Join an expert-led discussion on the pathophysiology of vitiligo, challenges in disease management, goals of therapy, and best practices for patient communication and shared decision-making
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Sponsored by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Chronic Hand Eczema: A New Day Is at Hand
FREE NON-CME Dermatology Webinar
Tuesday, September 30, 2025 | 5:00 - 6:00 PM PDT
Lakshi M. Aldredge, MSN ANP-BC DCNP FAANP
Valerie Stern, DMSc MPAS PA-C
DAYS
HRS
MIN
SEC
Chronic hand eczema (CHE) can disrupt daily life and confidence. Explore the latest mechanisms behind CHE including immune pathways and barrier dysfunction and discover advanced treatments from topical breakthroughs to targeted systemic therapies. Learn practical strategies to personalize care, manage triggers, and empower patients to break the flare cycle for lasting relief.
Learning Objectives:
Describe the clinical presentation, epidemiology, and impact of chronic hand eczema on patients’ daily lives.
Differentiate the major subtypes of chronic hand eczema and understand their specific disease burdens.
Review the immunologic and barrier-related mechanisms underlying each CHE subtype and how these inform targeted therapies.
Apply evidence-based strategies for assessing disease severity and selecting appropriate treatment options, including topical, systemic, and emerging therapies.
Integrate knowledge of CHE pathophysiology, subtypes, and management into practical approaches to improve patient outcomes and quality of life.
Join us LIVE!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
Atopic Dermatitis: Pathways to Personalized and Long-Term Care
FREE NON-CME Dermatology Webinar
Tuesday, January 20, 2026 | 5:00 - 6:00 PM PST
Peter Lio, MD
Sarina Elmariah, MD
Joanna L. Rosen, PsyD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Lilly, AbbVie, and LEO Pharma and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This session provides a practical, mechanism-based review of atopic dermatitis, highlighting the key immunologic pathways and skin barrier dysfunction that drive disease expression. These foundations will be translated into personalized, evidence-informed treatment strategies aligned with disease severity and individual patient needs. The session also explores real-world management considerations including flare control, adherence, and quality-of-life challenges while outlining approaches for long-term care planning. Participants will leave with up-to-date insight into emerging therapies and how to thoughtfully position them within the modern AD treatment landscape.
Learning Objectives:
Segment 1: Pathophysiology and Personalized Approaches (30 mins)
-Examine immunologic drivers of AD and their clinical implications.
-Understand skin barrier dysfunction and its therapeutic implications.
-Stratify treatment based on severity and endotype-driven selection.
Segment 2: Practical Management and Long-Term Control (30 mins)
-Explore real-world treatment strategies and long-term care planning.
-Address flares, adherence, and patient quality-of-life challenges.
-Review updates on emerging therapies and their clinical positioning.
Join us LIVE!
Be part of the experience—gain valuable insights and real-time engagement!
Supported by
ABBV-US-02401-E
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Modern Management of Alopecia Areata: Innovation Meets Compassion
FREE NON-CME Dermatology Webinar
Tuesday, December 16, 2025 | 5:00 - 6:00 PM PST
Paradi Mirmirani, MD
Jennifer Fu, MD
Joanna L. Rosen, PsyD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Lilly and AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This comprehensive session explores alopecia areata through both scientific and clinical lenses, offering an in-depth review of the evolving understanding and management of this complex autoimmune condition. The first segment will examine the immunopathogenesis of alopecia areata and highlight key advances in targeted therapies, including emerging JAK inhibitors and biologic agents. The second segment will focus on the patient experience addressing the psychosocial impacts, communication strategies, and practical integration of new therapies into clinical practice. Participants will gain actionable insights for optimizing patient outcomes and implementing evidence-based, compassionate care.
Learning Objectives:
Segment 1: Immunopathogenesis and Treatment Innovation (30 mins)
- Discuss an overview of disease mechanisms and autoimmune targeting.
- Review current and emerging JAK inhibitor therapies.
- Discuss biologic rationale and trial data insights.
Segment 2: Patient Impact and Practice Integration (30 mins)
- Explore mental health impacts and patient-centered communication.
- Identify referral pathways and access considerations.
- Share case-based approaches to diagnosis and treatment planning.
Discuss common misconceptions and underlying pathogenesis of vitiligo
Understand the impact of the psychosocial burden of vitiligo on patients
Explore the importance of setting personalized treatment goals and expectations, tailored to individual patient needs, and recognizing progress through meaningful goal achievement
Join us LIVE!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
ABBV-US-02401-E
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Beyond the Skin: Addressing the Drivers, Psychosocial Impact and Role of Goal Setting in Vitiligo Care
FREE NON-CME Dermatology Webinar
Tuesday, September 23, 2025 | 5:00 - 6:00 PM PDT
Mehdi Rashighi, MD
Erik Domingues, MD FAAD
Joanna L. Rosen, PsyD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This webinar will examine the psychosocial impact of vitiligo and examine how timely, individualized care can improve quality of life and patient outcomes.
Learning Objectives:
Discuss common misconceptions and underlying pathogenesis of vitiligo
Understand the impact of the psychosocial burden of vitiligo on patients
Explore the importance of setting personalized treatment goals and expectations, tailored to individual patient needs, and recognizing progress through meaningful goal achievement
Join us LIVE!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
ABBV-US-02401-E
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Essential TrutHS About HS: Deepening Knowledge and Elevating Patient Care
FREE NON-CME Dermatology Webinar
Tuesday, March 10, 2026 | 5:00 PM - 6:00 PM PDT
Tiffany Mayo, MD
Erika Page
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Incyte Corporation and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
For patients with hidradenitis suppurativa (HS), every day can be a challenge, and the impact goes beyond the skin. Join us to gain comprehensive knowledge about HS and an understanding of care options for this patient population.
Learning Objectives:
Recognize HS severity, impact on patient lives, and opportunities for advanced care
Review current treatment options and the importance of early effective management
Identify key pathways in the pathogenesis of HS and the role of JAK1
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Advancing Patient Care in Vitiligo: Insights and Practical Management Strategies
FREE NON-CME Dermatology Webinar
Tuesday, October 14, 2025 | 4:00 PM - 5:00 PM PDT
Iltefat Hamzavi, MD
Erika Page
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Incyte Corporation and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Please join us for an expert-led discussion on the pathophysiology of vitiligo, challenges in disease management, goals of therapy, and best practices for patient communication and shared decision-making. We will also gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making.
Learning Objectives:
Join an expert-led discussion on the pathophysiology of vitiligo, challenges in disease management, goals of therapy, and best practices for patient communication and shared decision-making
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Explore EBGLYSS® (lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
FREE NON-CME Dermatology Webinar
Tuesday, November 4, 2025 | 5:00 PM - 6:00 PM PDT
Nicole Chase MD, FAAP, FAAAAI, FACAAI
DAYS
HRS
MIN
SEC
This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com.
Please see Instructions for Use included with the device.EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases.
Learning Objectives:
Join an expert-led discussion on the pathophysiology of vitiligo, challenges in disease management, goals of therapy, and best practices for patient communication and shared decision-making
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Sponsored by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
For safety information, refer to the prescribing details below.
Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
FREE NON-CME Dermatology Webinar
Tuesday, October 21, 2025 | 5:00 PM - 6:00 PM PDT
Edward (Ted) Lain, MD
DAYS
HRS
MIN
SEC
This event is brought to you by Eli Lilly and Company. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases.
Learning Objectives:
Understand the mechanism of action of lebrikizumab-lbkz in targeting IL-13
Review clinical trial data on the efficacy and safety of EBGLYSS™
Identify appropriate patient candidates for lebrikizumab-lbkz
Discuss strategies for integrating lebrikizumab-lbkz into clinical practice
Join us live! Be part of the experience—don’t miss out!
Sponsored by
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
MAT-US-2407348 – v1.0 – P Exp Date: 01/10/2025
SAFETY SUMMARY
Warnings – Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
- Have a parasitic (helminth) infection.
- Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
- Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
- Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Possible side effects
EBGLYSS can cause serious side effects, including:
- Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:
- breathing problems or wheezing
- swelling of the face, lips, mouth, tongue or throat
- hives
- itching
- fainting, dizziness, feeling lightheaded
- skin rash
- cramps in your stomach area (abdomen)
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.
The most common side effects of EBGLYSS include:
- eye and eyelid inflammation, including redness, swelling, and itching
- injection site reactions
- shingles (herpes zoster)
These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How to take
- See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.
- Use EBGLYSS exactly as prescribed by your healthcare provider.
- EBGLYSS is given as an injection under the skin (subcutaneous injection).
- If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver.
- If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.
Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com
This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.
LK CON BS AD APP
INDICATION
EBGLYSS™ (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
UPCOMING MASTER CLASSES AND LIVE CME LECTURES
NON-CME
Modern Management of Alopecia Areata: Innovation Meets Compassion
December 16, 2025 | 5:00 PM - 6:00 PM PST
Paradi Mirmirani, MD
Jennifer Fu, MD
Live Non-CME
This comprehensive session explores alopecia areata through both scientific and clinical lenses, offering an in-depth review of the evolving understanding and management of this complex autoimmune condition. The first segment will examine the immunopathogenesis of alopecia areata and highlight key advances in targeted therapies, including emerging JAK inhibitors and biologic agents. The second segment will focus on the patient experience addressing the psychosocial impacts, communication strategies, and practical integration of new therapies into clinical practice. Participants will gain actionable insights for optimizing patient outcomes and implementing evidence-based, compassionate care.
Learning Objectives:
Segment 1: Immunopathogenesis and Treatment Innovation (30 mins)
- Discuss an overview of disease mechanisms and autoimmune targeting.
- Review current and emerging JAK inhibitor therapies.
- Discuss biologic rationale and trial data insights.
Segment 2: Patient Impact and Practice Integration (30 mins)
- Explore mental health impacts and patient-centered communication.
- Identify referral pathways and access considerations.
- Share case-based approaches to diagnosis and treatment planning.
Sponsored by Lilly and Abbvie
NON-CME
Essential TrutHS About HS: Deepening Knowledge and Elevating Patient Care
March 10, 2026 | 5:00 PM - 6:00 PM PST
Tina Bhutani, MD MAS
G. Michael Lewitt, MD
Live Non-CME
This session provides an up-to-date review of the evolving psoriasis treatment landscape, highlighting how to thoughtfully select and personalize biologic therapies based on individual patient profiles. Faculty will explore emerging combination and sequencing strategies for moderate-to-severe disease, offering practical insights for real-world decision-making. The session also examines the systemic nature of psoriasis, including its associations with cardiometabolic disease, and outlines best practices for comorbidity screening and whole-patient care. Participants will gain guidance on integrating quality-of-life considerations and long-term management planning into comprehensive treatment approaches.
Learning Objectives:
Segment 1: Evolving Therapies and Personalization (30 mins) – Michael G. Lewitt, MD
- Explore the current and emerging therapeutic landscape.
- Discuss biologic selection and treatment tailoring based on patient profiles.
- Introduce combination and sequencing strategies for moderate-to-severe PsO.
Segment 2: Systemic Implications and Whole-Patient Care (30 mins) – Tina Bhutani, MD MAS
- Address the links between psoriasis, cardiometabolic disease, and systemic inflammation.
- Review comorbidity screening and integrated care approaches.
- Highlight quality-of-life and long-term management considerations.
Supported by Lilly
NON-CME
Skin Nutrition and Biological Age
February 10, 2026 | 5:00 PM - 6:00 PM PST
raja Sivamani, MD MS AP
Apple Bodemer, MD
Peter Lio, MD
Live Non-CME Lecture
Skin aging reflects not only chronological time but also underlying biological processes influenced by nutrition, metabolism, inflammation, and lifestyle. Emerging research highlights how dietary patterns, micronutrients, gut health, and metabolic resilience shape skin structure, function, and visible aging. This session will explore the concept of biological age as it relates to skin health, with a focus on nutritional and integrative strategies that support cellular repair, collagen integrity, barrier function, and healthy aging across the lifespan. Dermatologists will gain practical, evidence-based tools to assess nutritional contributors to skin aging and to incorporate targeted interventions into patient care. Case-based discussions will demonstrate how to translate these insights into real-world clinical practice. Following the lecture, we’ll share information about the Integrative Dermatology Certificate Program (IDCP) and resources for advancing an integrative, longevity-focused dermatology practice. Join us for an engaging evening of expert discussion and live Q&A.
Learning Objectives:
- Discuss the concept of biological age and its relevance to skin structure, function, and visible aging.
- Review the role of nutrition, metabolic health, inflammation, and the gut-skin axis in skin aging.
- Identify key nutrients, dietary patterns, and supplements that support skin longevity and repair.
- Apply practical, evidence-based strategies to assess and address nutritional factors influencing skin aging in clinical dermatology practice.
NON-CME
Obesity in Dermatology: Managing Metabolic Inflammation and Lifestyle Integration
January 6, 2026 | 5:00 PM - 6:00 PM PST
Raja Sivamani, MD MS AP
Jason Hawkes, MD MS
Erin Barrett, MD
Live Non-CME Lecture
This session explores the connection between adipose tissue, systemic inflammation, and their downstream effects on dermatologic disease, highlighting key metabolic pathways that influence skin outcomes. Faculty will also introduce incretin-based therapies and discuss their emerging relevance in inflammatory skin conditions. Building on this foundation, the session provides practical, time-efficient strategies for initiating lifestyle conversations in busy dermatology settings, with examples of achievable diet and exercise recommendations. Participants will leave with actionable approaches for integrating lifestyle interventions into comprehensive dermatologic care plans.
Learning Objectives:
Segment 1: Inflammation, Weight, and Dermatologic Outcomes (30 mins)
- Explain how adipose tissue contributes to chronic systemic and cutaneous inflammation.
- Explore the clinical relevance of metabolic pathways in dermatologic disease.
- Introduce incretin-based therapies and their emerging role in inflammatory skin conditions.
Segment 2: Lifestyle Strategies for Dermatology Practice (30 mins)
- Describe efficient methods for initiating lifestyle discussions during short dermatology visits.
- Provide practical examples of achievable diet and exercise recommendations.
- Discuss how to integrate lifestyle interventions into dermatologic care plans.
Sponsored by Lilly
NON-CME
Atopic Dermatitis: Pathways to Personalized and Long-Term Care
January 20, 2026 | 5:00 PM - 6:00 PM PST
Peter Lio, MD
Sarina Elmariah, MD
Live Non-CME Lecture
This session provides a practical, mechanism-based review of atopic dermatitis, highlighting the key immunologic pathways and skin barrier dysfunction that drive disease expression. These foundations will be translated into personalized, evidence-informed treatment strategies aligned with disease severity and individual patient needs. The session also explores real-world management considerations including flare control, adherence, and quality-of-life challenges while outlining approaches for long-term care planning. Participants will leave with up-to-date insight into emerging therapies and how to thoughtfully position them within the modern AD treatment landscape.
Learning Objectives:
Segment 1: Pathophysiology and Personalized Approaches (30 mins)
- Examine immunologic drivers of AD and their clinical implications.
- Understand skin barrier dysfunction and its therapeutic implications.
- Stratify treatment based on severity and endotype-driven selection.
Segment 2: Practical Management and Long-Term Control (30 mins)
- Explore real-world treatment strategies and long-term care planning.
- Address flares, adherence, and patient quality-of-life challenges.
- Review updates on emerging therapies and their clinical positioning.
Sponsored by Lilly and AbbVie
NON-CME
Unraveling the Mystery: The Role of Type 2 Inflammation Across AD, PN, CSU, and BP
December 9, 2025 | 5:00 PM - 6:00 PM PST
Raj Chovatiya, MD PhD MSCI
Jason Hawkes, MD MS
Erin Barrett, MD
Live Non-CME Lecture
Join experts Raj Chovatiya, MD, PhD, MSCI; Jason Hawkes, MD, MS; and Erin Barrett, MD, at the educational ADVENT LearnSkin 2025 Cross-Dermatology Webinar, where they will explore the clinical similarities and differences among AD, PN, CSU, and BP. The discussion will highlight the significance of type 2 inflammation as a common thread in the signs and symptoms of these conditions, as well as the shared and unique inflammatory pathways underlying their pathophysiology.
Learning Objectives:
- Understand the clinical similarities and differences in AD, PN, CSU, and BP
- Describe the significance of type 2 inflammation in underlying the clinical signs and symptoms of AD, PN, CSU, and BP
- Highlight shared and unique type 2 inflammatory pathways in the pathophysiology of these chronic inflammatory dermatology conditions
Sponsored by Sanofi and Regeneron Pharmaceuticals
NON-CME
Modern Management of Alopecia Areata: Innovation Meets Compassion
December 16, 2025 | 5:00 PM - 6:00 PM PST
Paradi Mirmirani, MD
Jennifer Fu, MD
Live Non-CME
This comprehensive session explores alopecia areata through both scientific and clinical lenses, offering an in-depth review of the evolving understanding and management of this complex autoimmune condition. The first segment will examine the immunopathogenesis of alopecia areata and highlight key advances in targeted therapies, including emerging JAK inhibitors and biologic agents. The second segment will focus on the patient experience addressing the psychosocial impacts, communication strategies, and practical integration of new therapies into clinical practice. Participants will gain actionable insights for optimizing patient outcomes and implementing evidence-based, compassionate care.
Learning Objectives:
Segment 1: Immunopathogenesis and Treatment Innovation (30 mins)
- Discuss an overview of disease mechanisms and autoimmune targeting.
- Review current and emerging JAK inhibitor therapies.
- Discuss biologic rationale and trial data insights.
Segment 2: Patient Impact and Practice Integration (30 mins)
- Explore mental health impacts and patient-centered communication.
- Identify referral pathways and access considerations.
- Share case-based approaches to diagnosis and treatment planning.
Sponsored by Lilly
THE SPEAKERS
We brought together medical experts that have devoted their time and energy to
advancing the field of integrative dermatology
Gary N. Harker
NON-CME MASTER CLASS
Safeguarding Wealth: Lawsuit Prevention and Tax Strategies1/21/25 | 5:00 PM PT
Martha Viera, MD
NON-CME MASTER CLASS
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PT
Cynthia Tie, MD
NON-CME MASTER CLASS
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PT
Asmi Berry , DO
NON-CME MASTER CLASS
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PT
Joseph Gretzula, DO FAAD
NON-CME MASTER CLASS
The power of Akkermansia and other novel probiotics: Supporting a holistic approach to beauty with targeted probiotic strains
Read Bio
1/14/25 | 5:00 PM PT
Christina O’Connor, RD
NON-CME MASTER CLASS
The power of Akkermansia and other novel probiotics: Supporting a holistic approach to beauty with targeted probiotic strains
Read Bio
1/14/25 | 5:00 PM PT
Eric Simpson, MD MCR
NON-CME MASTER CLASS
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology9/10/24 | 5:00 PM PT
April Armstong, MD MPH
NON-CME MASTER CLASS
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology9/10/24 | 5:00 PM PT
Victoria Werth, MD
NON-CME MASTER CLASS
Exploring Bullous Pemphigoid: Bridging Research and Clinical Practice10/22/24 | 5:00 PM PT
Kara Siedman, RD CDCES
NON-CME MASTER CLASS
Treating the Root Cause of Eczema: The Gut Microbiome Connection
Read Bio
11/5/24 | 5:00 PM PT
Sarina Elmariah, MD PhD
NON-CME MASTER CLASS
Scratching the Surface: Understanding Itch in Prurigo Nodularis8/13/24 | 5:00 PM PT
Teri M Greiling, MD PhD FAAD
NON-CME MASTER CLASS
Exploring Bullous Pemphigoid: Bridging Research and Clinical Practice10/22/24 | 5:00 PM PT
Raja Sivamani, MD MS AP
MASTER CLASSES AND LECTURES
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PST
Jason Hawkes, MD MS FAAD
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Brennan Dedecker, ND
NON-CME MASTER CLASS
Elevate Your Membership: The Extraordinary World of Premium
Read Bio
3/12/24 | 5:00 PM PST
Raj Chovatiya, MD PhD MSCI FAAD
Tina Bhutan, MD MAS
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psotiasis - Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Neal Bhatia, MD
MASTER CLASSES AND LECTURES
Case-Based Learning: Difficult Psotiasis - Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Ted Lain, MD MBA
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psoriasis - Challenges from the clinic 6/4/24 | 5:00 PM PST
Read Bio
Julie Harper, MD
NON-CME MASTER CLASS
Non-CME
New Insights into Managing Acne Through a Novel Nutraceutical11/12/24 | 5:00 PM PST
Read Bio
New Insights into Managing Acne Through a Novel Nutraceutical11/12/24 | 5:00 PM PST
WATCH RECORDINGS
Catch Up on the Latest Advancements in Dermatology
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
This webinar covers integrative approaches to hair health and recovery after aesthetic treatments like lasers, microneedling, and chemical peels. It highlights growth factor delivery and expert insights on advanced post-procedure care and innovations in hair restoration. Gain a comprehensive understanding of optimizing hair health and achieving better treatment outcomes.
Sponsored by NeoGenesis Inc.
Non-CME
The Power of Akkermansia and Other Novel Probiotics: Supporting a Holistic Approach to Beauty with Targeted Probiotic Strains
Discover the vital role of the gut microbiome, especially Akkermansia muciniphila, in natural GLP-1 production, weight management, and overall wellness. Join Dr. Joseph Gretzula and Christina O’Connor, RD, to explore how this microbe supports aesthetic goals. Learn actionable strategies to integrate gut health into your practice for a holistic approach to beauty and well-being.
Supported by Pendulum Therapeutics
Non-CME
Safeguarding Wealth: Lawsuit Prevention and Tax Strategies
Legally Mine will show you how to stop the threat of lawsuits before they ever get started by protecting your assets in time tested and proven legal structures. These same structures allow us to help our tax attorneys save what you would normally pay in income taxes. These are little known tax helps that have significant case history and have stood the test of time.
Sponsored by Legally Mine
Non-CME
New Insights into Managing Acne Through a Novel Nutraceutical
This master class discusses the evidence supporting the role of the six factors in the development of acne. It also presents clinical results from the use of a novel nutraceutical which addresses these root causes in subjects with non-cystic acne.
Non-CME
Treating the Root Cause of Eczema: The Gut Microbiome Connection
In this webinar, you’ll learn about the role Akkermansia muciniphila plays in the gut-skin axis and review case studies showing how addressing gut health can lead to effective treatments for eczema.
Non-CME
Exploring Bullous Pemphigoid: Bridging Research and Clinical Practice
Join experts Drs. Victoria Werth and Teri Greiling for an educational webinar about diverse clinical presentations, diagnostic challenges, and pathophysiology in BP.
Supported by ADVENT (Sanofi and Regeneron)
Non-CME
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
Join experts Drs. Eric Simpson and April Armstrong at an ADVENT educational webinar where they will discuss the role of type 2 inflammation in atopic hand and foot dermatitis.
Sponsored by ADVENT (Sanofi and Regeneron)
NON-CME
Scratching the Surface: Understanding Itch in Prurigo Nodularis
Join experts Drs. Sarina Elmariah and Raja Sivamani at an educational ADVENT webinar as they unravel prurigo nodularis as an itchy dermatological condition. Uncover how clinical signs and itch in prurigo nodularis are impacted by type 2 inflammation. Discover diagnostic and management considerations for clinical practice. Sponsored by ADVENT (Sanofi and Regeneron)
NON-CME
Emerging and Novel Over-The-Counter Retinoids: Innovations in Dermatology
This masterclass will focus on a new retinoid ingredient Adapinoid and the emerging clinical evidence in comparison to retinol.
Supported by Actera
Non-CME
An Integrative Approach to Hormones and Stress in Dermatology
Join us for this master class to explore the intricate relationship between hormonal imbalances, stress, and skin health. Dermatological conditions often stem from internal factors such as hormonal fluctuations and psychological stressors, in addition to external influences.Supported by Codex Labs
Non-CME
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
This webinar will review complex cases of psoriasis and psoriatic arthritis and discuss the clinical approach to diagnosis, selection of therapy, and comprehensive long-term management of the disease and overall patient care.
Supported by independent educational grants from Janssen Biotech, Inc and UCB
Non-CME
Chronic Hand Eczema
This lecture focuses on Chronic Hand Eczema (CHE), a persistent dermatological condition with significant implications on patient quality of life and psychological well-being. Leading dermatologist, Dr. Raj Chovatiya, presents current insights into the epidemiology, pathogenesis, diagnosis, and management of CHE.
Supported by LEO Pharma
Non-CME
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
This webinar will review complex cases of psoriasis and psoriatic arthritis and discuss the clinical approach to diagnosis, selection of therapy, and comprehensive long-term management of the disease and overall patient care.
Supported by independent educational grants from Janssen Biotech, Inc and UCB
Non-CME
Chronic Hand Eczema
This lecture focuses on Chronic Hand Eczema (CHE), a persistent dermatological condition with significant implications on patient quality of life and psychological well-being. Leading dermatologist, Dr. Raj Chovatiya, presents current insights into the epidemiology, pathogenesis, diagnosis, and management of CHE.
Supported by LEO Pharma
Non-CME
Elevate Your Membership: The Extraordinary World of Premium
Premium membership has a lot to offer, and you might be wondering where to start? Join us as we explore key features of the LearnSkin platform and how to optimize the educational content and resources for your professional advancement and patient care. Discover exclusive perks available only to premium members and walk through cases using the new Natural Medicines Database (NMD) integration. Connect with like-minded colleagues and elevate your practice!
Non-CME
Psoriasis Case Discussions: Approach to All Disease Variants
This session will focus on case presentations featuring patients that have psoriasis and highlight our psoriasis and seborrheic dermatitis CME series.
Non-CME
Sign Up
You don't want to miss out on learning practical pearls to better help your patient's physical and mental health within dermatology.
WHO IS LEARNSKIN
LearnSkin is a dedicated group of dermatologists and integrative medicine practitioners with a mission to support professionals in dermatology. Their goal is to share the latest scientific research and treatment options in dermatology for both Western and Eastern medicine to meet the growing demand for responsible, quality, and evidence-based education bridging conventional and complementary medical approaches.
LearnSkin master classes, programs, and events are designed to provide clinicians like you with skills that expand past what was learned in school, residency, and traditional conferences with the hope you inspire change in your patients and reach better outcomes in their overall care.
Sponsor Prize
RAFFLE PRIZES
Attendees are automatically entered into a drawing to win a prize from LearnSkin or the dermatology webinar sponsor. You must attend live to be eligible and to claim your prize!
SPONSORS
ABBVIE
ACTIVE SKIN REPAIR
AYUSH HERBS
BIOCIDIN
CODEX LABS
DERMELEVE
DIAGNOSTIC SOLUSTIONS LAB
DUTCH TEST BY PRECISION ANALYTICAL
LILLY
REGENERON AND SANOFI
RESULTS RNA
Copyright 2023 © LearnHealth Inc. All rights reserved.